AHMED NADIM Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$100,316.00
Insider Sells Quantity
7
Insider Sells Sum
$276,177.80

Insider Activity of AHMED NADIM

According to the SEC Form 4 filings, AHMED NADIM, being in a position of

  1. President and CEO at Cullinan Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 39818 shares for $517,990,
    over all time since 2022-06-06, has bought 8090 shares for $100,316, and sold 67907 shares for $794,168.

Biography of AHMED NADIM

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $517,9903100

Comparison of Insiders on Amount of Buys and Sells

2026-02-24SaleCullinan Therapeutics, Inc.
CGEM
President and CEO
13,515
0.0232%
$14.47$195,562+8.34%
2026-02-20SaleCullinan Therapeutics, Inc.
CGEM
President and CEO
16,381
0.0277%
$13.62$223,109+13.19%
2025-12-23SaleCullinan Therapeutics, Inc.
CGEM
President and CEO
9,922
0.0163%
$10.01$99,319+49.35%
2025-02-25SaleCullinan Oncology, Inc.
CGEM
President and CEO
12,529
0.0203%
$8.53$106,872-4.91%
2024-12-24SaleCullinan Oncology, Inc.
CGEM
President and CEO
8,400
0.014%
$11.87$99,708-33.7%
2023-12-26SaleCullinan Oncology, Inc.
CGEM
President and CEO
4,272
0.0096%
$9.24$39,473+76.48%
2023-06-28SaleCullinan Oncology, Inc.
CGEM
President and CEO
759
0.0019%
$11.40$8,653-3.02%
2023-05-23SaleCullinan Oncology, Inc.
CGEM
President and CEO
707
0.0017%
$9.15$6,469+17.56%
2023-04-25SaleCullinan Oncology, Inc.
CGEM
President and CEO
716
0.0018%
$10.59$7,582-0.24%
2023-03-23SaleCullinan Oncology, Inc.
CGEM
President and CEO
706
0.0017%
$10.51$7,420-2.65%
2022-06-06PurchaseCullinan Oncology, Inc.
CGEM
President and CEO
8,090
0.0182%
$12.40$100,316-3.42%
Total: 11
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.